Cargando…

Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence

Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8(+) T cell compartment and elevated plasma TNF‐α but in later follow‐up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient remains to be elucidated, however, late adverse effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lázničková, Petra, Kepák, Tomáš, Hortová – Kohoutková, Marcela, Horváth, Luděk, Sheardová, Kateřina, Marciniak, Rafal, Vacca, Carmine, Šiklová, Michaela, Zelante, Teresa, Rossmeislová, Lenka, Křenová, Zdenka, Štěrba, Jaroslav, Bendíčková, Kamila, Frič, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754117/
https://www.ncbi.nlm.nih.gov/pubmed/32744364
http://dx.doi.org/10.1002/eji.202048541
_version_ 1783626128801398784
author Lázničková, Petra
Kepák, Tomáš
Hortová – Kohoutková, Marcela
Horváth, Luděk
Sheardová, Kateřina
Marciniak, Rafal
Vacca, Carmine
Šiklová, Michaela
Zelante, Teresa
Rossmeislová, Lenka
Křenová, Zdenka
Štěrba, Jaroslav
Bendíčková, Kamila
Frič, Jan
author_facet Lázničková, Petra
Kepák, Tomáš
Hortová – Kohoutková, Marcela
Horváth, Luděk
Sheardová, Kateřina
Marciniak, Rafal
Vacca, Carmine
Šiklová, Michaela
Zelante, Teresa
Rossmeislová, Lenka
Křenová, Zdenka
Štěrba, Jaroslav
Bendíčková, Kamila
Frič, Jan
author_sort Lázničková, Petra
collection PubMed
description Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8(+) T cell compartment and elevated plasma TNF‐α but in later follow‐up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient remains to be elucidated, however, late adverse effects often occur in childhood cancer survivors. [Image: see text]
format Online
Article
Text
id pubmed-7754117
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77541172020-12-23 Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence Lázničková, Petra Kepák, Tomáš Hortová – Kohoutková, Marcela Horváth, Luděk Sheardová, Kateřina Marciniak, Rafal Vacca, Carmine Šiklová, Michaela Zelante, Teresa Rossmeislová, Lenka Křenová, Zdenka Štěrba, Jaroslav Bendíčková, Kamila Frič, Jan Eur J Immunol Letters to the Editor Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8(+) T cell compartment and elevated plasma TNF‐α but in later follow‐up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient remains to be elucidated, however, late adverse effects often occur in childhood cancer survivors. [Image: see text] John Wiley and Sons Inc. 2020-08-18 2020-12 /pmc/articles/PMC7754117/ /pubmed/32744364 http://dx.doi.org/10.1002/eji.202048541 Text en © 2020 The Authors. European Journal of Immunology published by Wiley‐VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Lázničková, Petra
Kepák, Tomáš
Hortová – Kohoutková, Marcela
Horváth, Luděk
Sheardová, Kateřina
Marciniak, Rafal
Vacca, Carmine
Šiklová, Michaela
Zelante, Teresa
Rossmeislová, Lenka
Křenová, Zdenka
Štěrba, Jaroslav
Bendíčková, Kamila
Frič, Jan
Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence
title Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence
title_full Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence
title_fullStr Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence
title_full_unstemmed Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence
title_short Childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence
title_sort childhood survivors of high‐risk neuroblastoma show signs of immune recovery and not immunosenescence
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754117/
https://www.ncbi.nlm.nih.gov/pubmed/32744364
http://dx.doi.org/10.1002/eji.202048541
work_keys_str_mv AT laznickovapetra childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT kepaktomas childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT hortovakohoutkovamarcela childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT horvathludek childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT sheardovakaterina childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT marciniakrafal childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT vaccacarmine childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT siklovamichaela childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT zelanteteresa childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT rossmeislovalenka childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT krenovazdenka childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT sterbajaroslav childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT bendickovakamila childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence
AT fricjan childhoodsurvivorsofhighriskneuroblastomashowsignsofimmunerecoveryandnotimmunosenescence